Cargando…
Development of an anti-CAR antibody response in SIV-infected rhesus macaques treated with CD4-MBL CAR/CXCR5 T cells
T cells expressing a simian immunodeficiency (SIV)-specific chimeric antigen receptor (CAR) and the follicular homing molecule, CXCR5, were infused into antiretroviral therapy (ART) suppressed, SIV-infected rhesus macaques to assess their ability to localize to the lymphoid follicle and control the...
Autores principales: | Davey, Brianna C., Pampusch, Mary S., Cartwright, Emily K., Abdelaal, Hadia M., Rakasz, Eva G., Rendahl, Aaron, Berger, Edward A., Skinner, Pamela J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793449/ https://www.ncbi.nlm.nih.gov/pubmed/36582226 http://dx.doi.org/10.3389/fimmu.2022.1032537 |
Ejemplares similares
-
Assessment of anti-CD20 antibody pre-treatment for augmentation of CAR-T cell therapy in SIV-infected rhesus macaques
por: Pampusch, Mary S., et al.
Publicado: (2023) -
CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection
por: Pampusch, Mary S., et al.
Publicado: (2022) -
Low levels of SIV-specific CD8+ T cells in germinal centers characterizes acute SIV infection
por: Li, Shengbin, et al.
Publicado: (2019) -
Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication
por: Haran, Kumudhini Preethi, et al.
Publicado: (2018) -
Cytotoxic Capacity of SIV-Specific CD8(+) T Cells against Primary Autologous Targets Correlates with Immune Control in SIV-Infected Rhesus Macaques
por: Mendoza, Daniel, et al.
Publicado: (2013)